Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI Partnership in CNS Oncology
Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI partnership raises…
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal to expand…
Lucid Diligence Brief: NeuroVision’s Durin Life Sciences acquisition
Lucid Diligence Brief: NeuroVision’s Durin Life Sciences acquisition…
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership…
Lucid Diligence Brief: Roche to acquire PathAI
Lucid Diligence Brief: Roche acquires PathAI for USD 1.05B to advance AI…
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration Professional…
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…
Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir in COPD
Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir…
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal…
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA biomarkers
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA…
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…